Rocket Pharmaceuticals, Inc. Stock Split Ratio
Rocket Pharmaceuticals, Inc. (RCKT) reported Stock Split Ratio of 83.54% for the 1-month period ending 2015-01-31, per its 10-K filed 2017-03-16.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2017-03-16
- 2015-01-31: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 83.54%; Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month as first filed 119.70%.
- 2014-11-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 29.50%; Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month as first filed 339.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month as first filed |
|---|---|---|
| 2015-01-31 | 83.54% 10-K · filed 2017-03-16 | 119.70% 10-Q · filed 2015-05-14 |
| 2014-11-30 | 29.50% 10-K · filed 2017-03-16 | 339.00% 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |